You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 16, 2026

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
Vivekkumar Patel1, Megumi Mathison1, Vivek P Singh1
1Michael E. DeBakey Department of Surgery, Baylor College of Medicine, 6501 Fannin Street, Suite NC114, Houston, TX, 77030, USA.
Directly reprogramming heart fibroblasts into new cardiomyocytes offers a promising therapy for heart failure. A combined approach using differentiation factors, fibroblast gene suppression, and angiogenic factors is likely most effective.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: